apexigen inc
Simcere To Begin Clinical Trials On VEGF Inhibitor
Simcere Pharma has received SFDA approval to begin first-in-man trials with its humanized monoclonal antibody candidate, APX003.
Simcere Pharma has received SFDA approval to begin first-in-man trials with its humanized monoclonal antibody candidate, APX003.